01 / VALUE CHAIN
Discovery & science
Research, clinical evidence, product development, regulatory qualification and intellectual-property protection.
· · Global investment perspectives
Health & Wellness
Preventive care, nutritional innovation and the economics of human wellbeing.
01 / Industry context
Healthier lives, longer horizons.
Human wellbeing is both a social priority and a substantial economic ecosystem. Demand for health services, nutrition, prevention, diagnostics and personal wellness responds to demographics, scientific advances and changing consumer habits. The commercial opportunity spans very different types of business: regulated health services, evidence-based products, software, manufacturing, distribution and consumer brands.
A large addressable market is a useful starting point, never a substitute for company-level research. An ageing population may support demand, but public policy, reimbursement, product efficacy, distribution costs and market competition decide whether individual companies can convert that demand into durable cash flow.
02 / The market in context
The market opportunity. The commercial forces.
Health is both an essential service and a constantly evolving consumer economy. Our focus is on businesses that turn better outcomes and consistent demand into resilient income.
US$6.8T
2024 global wellness economy
GWI estimates the broad wellness economy reached US$6.8 trillion in 2024. The breadth of the market creates a varied set of opportunities across services and consumer businesses.7.6% p.a.
2024–2029 projected wellness growth
The Global Wellness Institute forecasts annual growth of 7.6% through 2029; reflecting growing activity across multiple wellness categories.Noralle reads these market signals alongside operating costs, revenue durability and the ability of businesses to convert demand into consistent cash generation.
03 / Economic structure
Where economic value is created.
Follow the business activity from origination to commercial delivery, then assess who has pricing power and who bears the largest costs.
02 / VALUE CHAIN
Production & distribution
Manufacturing quality, inventory management, trusted channels and access to providers or consumers.
03 / VALUE CHAIN
Services & engagement
Health services, monitoring, recurring customer support, prevention and responsible product communication.
04 / Noralle investment thesis
Why Noralle invests in Health & Wellness.
The strongest health businesses earn trust before they earn scale. We focus on evidence-backed services, reliable product quality, recurring demand and distribution models capable of preserving healthy cash flow as they expand.
Explore all seven industries ↗
05 / Profitability analysis
The profit engines behind the industry.
Profit is earned through disciplined decisions about pricing, capacity, financing, execution and long-term demand. Noralle evaluates health & wellness through commercial fundamentals and repeatable operating performance—not market excitement alone.
How revenue is earned
Clinical or service fees, subscriptions, reimbursed treatments, product sales, licenses and distribution agreements; the mix differs markedly between healthcare and consumer wellness.
What shapes profit margins
Gross margin reflects production and delivery costs; operating margin also reflects clinical staff, research, marketing, insurance and compliance. Product innovation can support pricing power, while reimbursement pressure and customer acquisition costs can compress returns.
What to measure
Gross and operating margins by segment; repeat-purchase and retention; clinical evidence; acquisition cost versus lifetime value; regulatory cost; cash conversion; working-capital intensity.
Comparative margin evidence / January 2026
Selected public-company net margins.
January 2026 NYU Stern / Damodaran U.S.-listed company profit-margin benchmarks add context to the profitability discussion. The company categories and accounting bases are identified below.
Healthcare Products9.61%204 U.S. listed companies
Healthcare Support Services1.25%104 U.S. listed companies
Source: NYU Stern / Aswath Damodaran, Margins by Sector (U.S. listed companies, January 2026) . Net margins represent the referenced U.S.-listed company samples.
We examine profitability through pricing power, delivery costs, operating discipline, cash conversion and the resilience of each business model.
Noralle / Sector managed capital / FY2025
Our commitment to Health & Wellness.
Noralle oversees £37.06bn in managed capital across its Health & Wellness investment focus. We allocate capital to health-related businesses because lasting demand for effective care, evidence-led products and accessible services supports durable commercial opportunities. Our members are part of this journey through transparent communication, practical education and a shared long-term perspective.
£37.06bnManaged capital in this sector
FundamentalsInvestment philosophy
ResearchOur decision process
MembersPart of Noralle
This allocation forms part of Noralle’ £300 billion managed-capital base. We combine sector knowledge, commercial analysis, active oversight and open communication to pursue opportunities with long-term relevance.
Explore the full investment landscape ↗Our members / Shared direction
More than investors. Part of Noralle.
A corporation grows stronger when the people who place their trust in it are informed, respected and involved in its thinking.
Our members are more than names beside a balance. Their confidence, questions, ideas and long-term ambitions are part of the Noralle story. We share our sector perspectives in accessible language so members can understand what we study, why we allocate attention and how market change influences our judgment.
Our members are part of the purpose behind the numbers. Their questions about preventive care, quality and long-term demand influence the issues we make central to our research updates.
We believe strong relationships are built through useful communication, measured expectations and a shared interest in the future of the industries shaping everyday life.
06 / What we would investigate
Questions before committing capital.
Research begins with fundamentals and competing explanations. Each potential business or asset requires evidence, a model that can be independently challenged, and sensitivity analysis.
Due-diligence priorities
- Evidence of safety, efficacy and legal marketing claims
- Regulatory exposure and reimbursement dependence
- Retention, distribution economics and cost of acquiring customers
- Unit economics, competitive positioning and real free cash flow
07 / Risks and uncertainty
Protecting value through changing conditions.
Research should separate mature cash-generating services from speculative breakthroughs. Published wellness market growth establishes scale but does not imply that any specific enterprise will earn the same growth rate or a positive margin.
Principal challenges
- Weak scientific evidence or adverse product outcomes
- Changing health regulation, reimbursement or labeling rules
- Expensive customer acquisition and fast-moving consumer preferences
- Clinical, privacy and reputational liabilities
08 / Source library
The evidence behind our view.
Our outlook brings together market publications, sector research, company economics and established asset-management principles. Explore the primary references used to analyze this industry.
- Global Wellness Institute, 2025 Global Wellness Economy Monitor
- NYU Stern / Aswath Damodaran, Margins by Sector (U.S. listed companies, January 2026)
- BlackRock FY2025 earnings release ↗
- State Street 2025 Investment Management results ↗
Noralle evaluates sectors through demand quality, earnings resilience, competitive positioning, operating margins and the perspective of its member community.
Related industries
